Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Animal Early Embryo Extract ceAF in Knee Osteoarthritis
NCT07902128Phase 1Recruiting
- Sponsor
- HygeianCells BioMedical
- Start
- Dec 2025
- Primary completion
- Mar 2027
- Countries
- 1
01
Overview
Phase 1, open-label trial of animal early embryo extract in knee osteoarthritis (OA) (4 arms), sponsored by HygeianCells BioMedical. Primary endpoints: Safety observation at 12 weeks, Change from baseline in knee joint X-ray findings at 12 weeks and 3 more. Started Dec 2025; status: recruiting.
02
Drugs
animal early embryo extract
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT07902128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07902128.